Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

TAVR on the weekend vs. weekdays | ICE & structural heart procedures | AI takes NLP to the next level | The consequences of PAD

News You Need to Know Today
TAVR on the weekend vs. weekdays | ICE & structural heart procedures | AI takes NLP to the next level | The consequences of PAD
Tuesday, February 4, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

TAVR patients admitted on weekend face greater risk of death, complications

The so-called "weekend effect" seen with other cardiovascular diseases appears to exist for patients with severe aortic stenosis as well. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

TAVR patients admitted on weekend face greater risk of death, complications

Share on Twitter Share on Facebook Share on Linkedin
The so-called "weekend effect" seen with other cardiovascular diseases appears to exist for patients with severe aortic stenosis as well. 
READ MORE >

Key details on the use of ICE to guide structural heart procedures

Scott Lim, MD, details his experience using intracardiac echo to help guide structural heart procedures with or without traditional TEE. One key benefit of ICE, he explained, is its ability to overcome imaging challenges posed by prior cardiac surgeries.

READ MORE >
D. Scott Lim, MD, medical director of the Advanced Cardiac Valve Center, and co-director of the Adult Congenital Heart Disease Center at University of Virginia (UVA) Health in Charlottesville, and an associate professor at the University British Columbia, explains how intracardiac echo (ICE) is increasingly being used to help guide structural heart procedures.
Share on Twitter Share on Facebook Share on Linkedin

Key details on the use of ICE to guide structural heart procedures

Share on Twitter Share on Facebook Share on Linkedin
D. Scott Lim, MD, medical director of the Advanced Cardiac Valve Center, and co-director of the Adult Congenital Heart Disease Center at University of Virginia (UVA) Health in Charlottesville, and an associate professor at the University British Columbia, explains how intracardiac echo (ICE) is increasingly being used to help guide structural heart procedures.
Scott Lim, MD, details his experience using intracardiac echo to help guide structural heart procedures with or without traditional TEE. One key benefit of ICE, he explained, is its ability to overcome imaging challenges posed by prior cardiac surgeries.
READ MORE >

More than words: AI takes NLP to the next level to identify signs of heart failure

Previous NLP algorithms for heart failure looked for certain words or phrases, but this updated model makes decisions based on clinical context. 

READ MORE >
robot reviewing heart data
Share on Twitter Share on Facebook Share on Linkedin

More than words: AI takes NLP to the next level to identify signs of heart failure

Share on Twitter Share on Facebook Share on Linkedin
robot reviewing heart data
Previous NLP algorithms for heart failure looked for certain words or phrases, but this updated model makes decisions based on clinical context. 
READ MORE >

Cardiologists help highlight ‘severe consequences’ of peripheral artery disease

Many PAD patients do not even know they have the disease until it is too late, leading to unnecessary amputations and increasing the risk of other adverse patient outcomes. Awareness is especially limited among Black and Hispanic adults, experts warn, creating an added sense of urgency when looking to accelerate patient education efforts.

READ MORE >
IVUS guidance during DES implantation boosts long-term outcomes in new study
Share on Twitter Share on Facebook Share on Linkedin

Cardiologists help highlight ‘severe consequences’ of peripheral artery disease

Share on Twitter Share on Facebook Share on Linkedin
IVUS guidance during DES implantation boosts long-term outcomes in new study
Many PAD patients do not even know they have the disease until it is too late, leading to unnecessary amputations and increasing the risk of other adverse patient outcomes. Awareness is especially limited among Black and Hispanic adults, experts warn, creating an added sense of urgency when looking to accelerate patient education efforts.
READ MORE >

Featured Articles

PCI before TAVR linked to better outcomes than performing both at once

Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.

READ MORE >
Heart cardiologists doctors surgery
Share on Twitter Share on Facebook Share on Linkedin

PCI before TAVR linked to better outcomes than performing both at once

Share on Twitter Share on Facebook Share on Linkedin
Heart cardiologists doctors surgery
Researchers explored data from more than 50,000 TAVR patients who presented with both severe aortic stenosis and stable coronary artery disease, sharing their findings in JACC: Cardiovascular Interventions.
READ MORE >

Cardiologist-supported bill to stop ‘harmful’ Medicare cuts returns to Congress

A bipartisan bill designed to block recent Medicare payment cuts has been reintroduced to Congress after failing to pass in 2024. Will things be any different this time around? 

READ MORE >
congress money legislation lawmaker bill senate house senator representative
Share on Twitter Share on Facebook Share on Linkedin

Cardiologist-supported bill to stop ‘harmful’ Medicare cuts returns to Congress

Share on Twitter Share on Facebook Share on Linkedin
congress money legislation lawmaker bill senate house senator representative
A bipartisan bill designed to block recent Medicare payment cuts has been reintroduced to Congress after failing to pass in 2024. Will things be any different this time around? 
READ MORE >

Swedish total artificial heart tech granted FDA’s humanitarian use designation

Realheart celebrated the news, noting that multiple preclinical trials focused on the technology's safety and effectiveness are currently underway.

READ MORE >
Realheart Total Artificial Heart
Share on Twitter Share on Facebook Share on Linkedin

Swedish total artificial heart tech granted FDA’s humanitarian use designation

Share on Twitter Share on Facebook Share on Linkedin
Realheart Total Artificial Heart
Realheart celebrated the news, noting that multiple preclinical trials focused on the technology's safety and effectiveness are currently underway.
READ MORE >

In Case You Missed It

Surgeons make history again with world’s first robotic implant of Abbott heart device

The historic LVAD implant was performed on a 35-year-old patient with advanced heart failure. His symptoms included kidney and lung deterioration.

READ MORE >
King Faisal Specialist Hospital and Research Center perform LVAD implant with robotic assistance
Share on Twitter Share on Facebook Share on Linkedin

Surgeons make history again with world’s first robotic implant of Abbott heart device

Share on Twitter Share on Facebook Share on Linkedin
King Faisal Specialist Hospital and Research Center perform LVAD implant with robotic assistance
The historic LVAD implant was performed on a 35-year-old patient with advanced heart failure. His symptoms included kidney and lung deterioration.
READ MORE >

Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025

It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.

READ MORE >
STS President Jennifer C. Romano, MD, MS, a congenital heart surgeon with Mott Children’s Hospital and professor with the University of Michigan (UM) Medical School, spoke with Cardiovascular Business to preview STS 2025.
Share on Twitter Share on Facebook Share on Linkedin

Q&A: Society of Thoracic Surgeons president previews the trends and technologies of STS 2025

Share on Twitter Share on Facebook Share on Linkedin
STS President Jennifer C. Romano, MD, MS, a congenital heart surgeon with Mott Children’s Hospital and professor with the University of Michigan (UM) Medical School, spoke with Cardiovascular Business to preview STS 2025.
It looked like the wildfires in Los Angeles could force STS to cancel its annual meeting, but the group worked with city officials and was able to carry on as planned. STS President Jennifer C. Romano, MD, MS, discussed that difficult decision and previewed the three-day event in a new interview.
READ MORE >

Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards

Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.

READ MORE >
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve. The Myval transcatheter heart valve (THV) is non-inferior to the Sapien 3 THV after one year, according to new transcatheter aortic valve replacement (TAVR) data published in The Lancet.
Share on Twitter Share on Facebook Share on Linkedin

Early outcomes with Myval TAVR valve comparable to popular devices from Medtronic, Edwards

Share on Twitter Share on Facebook Share on Linkedin
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve. The Myval transcatheter heart valve (THV) is non-inferior to the Sapien 3 THV after one year, according to new transcatheter aortic valve replacement (TAVR) data published in The Lancet.
Meril Life Sciences has been manufacturing its Myval heart valves for years. The devices are approved and available in both India and Europe, but they have not been approved by the FDA.
READ MORE >

In Other News

GE HealthCare invests $138M in new contrast media manufacturing site amid rising demand

Leaders estimate the hub will generate about 25 million additional does of iodine-based imaging agents annually by the end of 2027. 

READ MORE >
GE HealthCare’s contrast media manufacturing site in Cork Ireland
Share on Twitter Share on Facebook Share on Linkedin

GE HealthCare invests $138M in new contrast media manufacturing site amid rising demand

Share on Twitter Share on Facebook Share on Linkedin
GE HealthCare’s contrast media manufacturing site in Cork Ireland
Leaders estimate the hub will generate about 25 million additional does of iodine-based imaging agents annually by the end of 2027. 
READ MORE >

FDA greenlights first non-opioid treatment for severe pain in 20 years

Journavax was shown in clinical trials to be safe and effective, with no addictive potential. 

READ MORE >
lumbar_back_pain.jpg
Share on Twitter Share on Facebook Share on Linkedin

FDA greenlights first non-opioid treatment for severe pain in 20 years

Share on Twitter Share on Facebook Share on Linkedin
lumbar_back_pain.jpg
Journavax was shown in clinical trials to be safe and effective, with no addictive potential. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Electrophysiology & Arrhythmia: The benefits of ablation | AVR for patients with aortic stenosis & AFib | Advanced AI
Weekend Edition: Blood clots & COVID-19 | Stark Law updates | Aortic stenosis & AFib | Hypertrophic cardiomyopathy
New technique could reduce MI-induced heart failure | Many type 2 MI patients not evaluated by a cardiologist
Practice Management: Top U.S. hospitals for cardiovascular care | Major Stark Law updates | TAVR's dominance
'We have never seen anything like this': COVID-19 & blood clots | CMS announces major Stark Law updates
Heart Failure: COVID-19 & myocarditis | Empagliflozin & HFrEF | Can the keto diet prevent HF?
Hypertension: High blood pressure during a pandemic | Pre-pregnancy hypertension on the rise

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …309
    • Page 310
    • Page 311
    • Page 312
    • Current page 313
    • Page 314
    • Page 315
    • Page 316
    • Page 317 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme
Trimed Popup